ViewRay, Inc.
VRAYQ
$0.00
$0.000.00%
| Weiss Ratings | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 37.33 | |||
| Price History | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.28% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 13, 2024 | |||
| 52-Week High Price (Date) | Apr 25, 2024 | |||
| Valuation | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 183.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -0.61 | |||
| Earnings Per Share Growth | -5.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 182.31M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 440 703 3210 | |||
| Address | 1099 18th Street Denver, CO 80202 | |||
| Website | www.viewray.com | |||
| Country | United States | |||
| Year Founded | 2004 | |||
| Profitability | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -101.51% | |||
| Profit Margin | -104.29% | |||
| Management Effectiveness | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -25.29% | |||
| Return on Equity | -- | |||
| Income Statement | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 105.86M | |||
| Total Revenue (TTM) | 105.86M | |||
| Revenue Per Share | $0.58 | |||
| Gross Profit (TTM) | 8.52M | |||
| EBITDA (TTM) | -102.73M | |||
| EBIT (TTM) | -107.47M | |||
| Net Income (TTM) | -110.42M | |||
| Net Income Avl. to Common (TTM) | -110.42M | |||
| Total Revenue Growth (Q YOY) | 19.38% | |||
| Earnings Growth (Q YOY) | -11.97% | |||
| EPS Diluted (TTM) | -0.61 | |||
| EPS Diluted Growth (Q YOY) | -10.39% | |||
| Balance Sheet | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 81.29M | |||
| Cash Per Share (Q) | $0.45 | |||
| Total Current Assets (Q) | 193.57M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 55.26M | |||
| Current Ratio (Q) | 1.161 | |||
| Book Value Per Share (Q) | $0.30 | |||
| Total Assets (Q) | 233.16M | |||
| Total Current Liabilities (Q) | 166.77M | |||
| Total Debt (Q) | 85.13M | |||
| Total Liabilities (Q) | 177.90M | |||
| Total Common Equity (Q) | 55.26M | |||
| Cash Flow | VRAYQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.86M | |||
| Cash from Financing (TTM) | 17.66M | |||
| Net Change in Cash (TTM) | -99.12M | |||
| Levered Free Cash Flow (TTM) | -72.17M | |||
| Cash from Operations (TTM) | -112.92M | |||
